Caladrius Biosciences Inc. (NASDAQ:CLBS) Stock Sees Selling Pressure At Higher Level

September 2, 2021

Caladrius Biosciences Inc. (NASDAQ: CLBS) fell 2.3% after announcing Dr. Kristen K. Buck’s appointment as the company’s Chief Medical Officer (CMO). Buck is joining the company from ICON plc, where she served in the position of CMO. She represented ICON’s position on major scientific, medical governance, and ethical matters and offered oversight and guidance to scientific and medical groups. Before that, she worked at Optum Insights as an SVP and…

Read More >>